<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Waldencast Acquisition Corp — News on 6ix</title>
    <link>https://6ix.com/company/waldencast-acquisition-corp</link>
    <description>Latest news and press releases for Waldencast Acquisition Corp on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Tue, 28 Apr 2026 22:12:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/waldencast-acquisition-corp" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835d57278dffbe2df121646.webp</url>
      <title>Waldencast Acquisition Corp</title>
      <link>https://6ix.com/company/waldencast-acquisition-corp</link>
    </image>
    <item>
      <title>Waldencast announces conclusion of SEC investigation</title>
      <link>https://6ix.com/company/waldencast-acquisition-corp/news/waldencast-announces-conclusion-of-sec-investigation</link>
      <guid isPermaLink="true">https://6ix.com/company/waldencast-acquisition-corp/news/waldencast-announces-conclusion-of-sec-investigation</guid>
      <pubDate>Tue, 28 Apr 2026 22:12:00 GMT</pubDate>
      <description>LONDON, April 28, 2026 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand beauty and wellness platform, announced today that it was notified by the staff of the U.S. Securities and Exchange Commission (the “SEC”) that they have concluded their investigation of the Company relating to Waldencast’s restatement of its financial results and material weaknesses in its internal control over financial reporting related to historical accounting practi</description>
    </item>
    <item>
      <title>Obagi Medical Introduces NU-GEN™ Cellular Renewal Serum Designed to Visibly Rewind Skin’s Age and Restore Visible Youthfulness</title>
      <link>https://6ix.com/company/waldencast-acquisition-corp/news/obagi-medical-introduces-nu-gentm-cellular-renewal-serum-designed-to-visibly-rewind-skins-age-and-restore-visible-youthfulness</link>
      <guid isPermaLink="true">https://6ix.com/company/waldencast-acquisition-corp/news/obagi-medical-introduces-nu-gentm-cellular-renewal-serum-designed-to-visibly-rewind-skins-age-and-restore-visible-youthfulness</guid>
      <pubDate>Tue, 24 Mar 2026 04:00:00 GMT</pubDate>
      <description>The clinically proven formula pairs NAD+ with its precursors to replenish skin cells and address nine signs of skin aging for healthier, more</description>
    </item>
    <item>
      <title>Obagi Medical and ProMD Announce Collaboration in the ALOHA Program to Advance Clinical Evidence with Obagi® saypha® MagIQ™</title>
      <link>https://6ix.com/company/waldencast-acquisition-corp/news/obagi-medical-and-promd-announce-collaboration-in-the-aloha-program-to-advance-clinical-evidence-with-obagir-sayphar-magiqtm</link>
      <guid isPermaLink="true">https://6ix.com/company/waldencast-acquisition-corp/news/obagi-medical-and-promd-announce-collaboration-in-the-aloha-program-to-advance-clinical-evidence-with-obagir-sayphar-magiqtm</guid>
      <pubDate>Thu, 19 Mar 2026 04:00:00 GMT</pubDate>
      <description>ProMD’s multi-location physician led network will participate in Obagi’s ALOHA Program as part of a structured evaluation of MagIQ and integrated skincare</description>
    </item>
    <item>
      <title>Waldencast Reports Q4 2025 and FY 2025 Financial Results</title>
      <link>https://6ix.com/company/waldencast-acquisition-corp/news/waldencast-reports-q4-2025-and-fy-2025-financial-results</link>
      <guid isPermaLink="true">https://6ix.com/company/waldencast-acquisition-corp/news/waldencast-reports-q4-2025-and-fy-2025-financial-results</guid>
      <pubDate>Fri, 13 Mar 2026 10:50:00 GMT</pubDate>
      <description>FY 2025 net revenue of $272.1 million, flat to FY 2024, and Adjusted EBITDA of $16.1 million Q4 2025 net revenue of $72.0 million, flat to Q4 2024 and Adjusted EBITDA of $6.6 million Obagi Medical sees continued revenue acceleration as a result of transformation efforts and continued brand momentum, alongside investments supporting the recent launch of its injectables platform Milk Makeup maintains U.S. consumption growth through distribution expansion, offset by softness in international market</description>
    </item>
    <item>
      <title>Waldencast plc Announces Fourth Quarter and Fiscal Year 2025 Earnings Date</title>
      <link>https://6ix.com/company/waldencast-acquisition-corp/news/waldencast-plc-announces-fourth-quarter-and-fiscal-year-2025-earnings-date-40</link>
      <guid isPermaLink="true">https://6ix.com/company/waldencast-acquisition-corp/news/waldencast-plc-announces-fourth-quarter-and-fiscal-year-2025-earnings-date-40</guid>
      <pubDate>Wed, 11 Mar 2026 04:00:00 GMT</pubDate>
      <description>LONDON, March 11, 2026 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform announced that its</description>
    </item>
    <item>
      <title>Obagi Medical and Schweiger Dermatology Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™</title>
      <link>https://6ix.com/company/waldencast-acquisition-corp/news/obagi-medical-and-schweiger-dermatology-announce-collaboration-in-the-aloha-program-to-drive-real-world-evidence-for-obagir-sayphar-magiqtm</link>
      <guid isPermaLink="true">https://6ix.com/company/waldencast-acquisition-corp/news/obagi-medical-and-schweiger-dermatology-announce-collaboration-in-the-aloha-program-to-drive-real-world-evidence-for-obagir-sayphar-magiqtm</guid>
      <pubDate>Fri, 27 Feb 2026 05:00:00 GMT</pubDate>
      <description>Schweiger selected as a leading dermatology platform partner due to its commitment to clinical excellence, rapid access to care, and dissemination across its</description>
    </item>
    <item>
      <title>Obagi Medical and It’s a Secret Med Spa Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™</title>
      <link>https://6ix.com/company/waldencast-acquisition-corp/news/obagi-medical-and-its-a-secret-med-spa-announce-collaboration-in-the-aloha-program-to-drive-real-world-evidence-for-obagir-sayphar-magiqtm</link>
      <guid isPermaLink="true">https://6ix.com/company/waldencast-acquisition-corp/news/obagi-medical-and-its-a-secret-med-spa-announce-collaboration-in-the-aloha-program-to-drive-real-world-evidence-for-obagir-sayphar-magiqtm</guid>
      <pubDate>Wed, 25 Feb 2026 05:00:00 GMT</pubDate>
      <description>It’s a Secret Med Spa selected as a premier luxury med spa partner due to its commitment to excellence, personalized luxury aesthetic experiences, and</description>
    </item>
    <item>
      <title>Obagi Medical and Aesthetic Record Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™</title>
      <link>https://6ix.com/company/waldencast-acquisition-corp/news/obagi-medical-and-aesthetic-record-announce-collaboration-in-the-aloha-program-to-drive-real-world-evidence-for-obagir-sayphar-magiqtm</link>
      <guid isPermaLink="true">https://6ix.com/company/waldencast-acquisition-corp/news/obagi-medical-and-aesthetic-record-announce-collaboration-in-the-aloha-program-to-drive-real-world-evidence-for-obagir-sayphar-magiqtm</guid>
      <pubDate>Tue, 17 Feb 2026 05:00:00 GMT</pubDate>
      <description>Aesthetic Record selected as a leading aesthetics EMR and practice management partner due to its commitment to technology innovation, operational efficiency,</description>
    </item>
    <item>
      <title>Obagi Medical and DermFx Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™</title>
      <link>https://6ix.com/company/waldencast-acquisition-corp/news/obagi-medical-and-dermfx-announce-collaboration-in-the-aloha-program-to-drive-real-world-evidence-for-obagir-sayphar-magiqtm</link>
      <guid isPermaLink="true">https://6ix.com/company/waldencast-acquisition-corp/news/obagi-medical-and-dermfx-announce-collaboration-in-the-aloha-program-to-drive-real-world-evidence-for-obagir-sayphar-magiqtm</guid>
      <pubDate>Fri, 06 Feb 2026 05:00:00 GMT</pubDate>
      <description>DermFx selected as a leading regional med spa partner due to its commitment to exceptional patient care, aesthetic innovation, and excellence across Southern</description>
    </item>
    <item>
      <title>Obagi Medical and Moxie Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™</title>
      <link>https://6ix.com/company/waldencast-acquisition-corp/news/obagi-medical-and-moxie-announce-collaboration-in-the-aloha-program-to-drive-real-world-evidence-for-obagir-sayphar-magiqtm</link>
      <guid isPermaLink="true">https://6ix.com/company/waldencast-acquisition-corp/news/obagi-medical-and-moxie-announce-collaboration-in-the-aloha-program-to-drive-real-world-evidence-for-obagir-sayphar-magiqtm</guid>
      <pubDate>Thu, 05 Feb 2026 05:00:00 GMT</pubDate>
      <description>Moxie selected as a leading aesthetic practice software and support partner for its commitment to innovation, compliance, and empowering aesthetic</description>
    </item>
    <item>
      <title>Obagi Medical Introduces New Lip Therapy Protocol Designed to Resurface, Replenish, and Protect</title>
      <link>https://6ix.com/company/waldencast-acquisition-corp/news/obagi-medical-introduces-new-lip-therapy-protocol-designed-to-resurface-replenish-and-protect</link>
      <guid isPermaLink="true">https://6ix.com/company/waldencast-acquisition-corp/news/obagi-medical-introduces-new-lip-therapy-protocol-designed-to-resurface-replenish-and-protect</guid>
      <pubDate>Tue, 03 Feb 2026 05:00:00 GMT</pubDate>
      <description>The dermatologist-tested duo pairs gentle chemical resurfacing with daily hydration and SPF protection for visibly smoother lips NEW YORK, Feb. 03, 2026</description>
    </item>
    <item>
      <title>Obagi Medical and VIO Med Spa Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™</title>
      <link>https://6ix.com/company/waldencast-acquisition-corp/news/obagi-medical-and-vio-med-spa-announce-collaboration-in-the-aloha-program-to-drive-real-world-evidence-for-obagir-sayphar-magiqtm</link>
      <guid isPermaLink="true">https://6ix.com/company/waldencast-acquisition-corp/news/obagi-medical-and-vio-med-spa-announce-collaboration-in-the-aloha-program-to-drive-real-world-evidence-for-obagir-sayphar-magiqtm</guid>
      <pubDate>Fri, 30 Jan 2026 05:00:00 GMT</pubDate>
      <description>VIO Med Spa selected as a key med spa franchise partner for its commitment to clinical excellence, innovation, and nationwide scalable aesthetic care NEW YORK</description>
    </item>
    <item>
      <title>Obagi Medical and Next Health Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™</title>
      <link>https://6ix.com/company/waldencast-acquisition-corp/news/obagi-medical-and-next-health-announce-collaboration-in-the-aloha-program-to-drive-real-world-evidence-for-obagir-sayphar-magiqtm</link>
      <guid isPermaLink="true">https://6ix.com/company/waldencast-acquisition-corp/news/obagi-medical-and-next-health-announce-collaboration-in-the-aloha-program-to-drive-real-world-evidence-for-obagir-sayphar-magiqtm</guid>
      <pubDate>Wed, 28 Jan 2026 05:00:00 GMT</pubDate>
      <description>Next Health selected as a leading wellness and longevity partner given its innovative approach to personalized aesthetics and health optimization NEW YORK and</description>
    </item>
    <item>
      <title>UPDATE - Obagi Medical and Alpha Aesthetic Partners Announce Their Collaboration in the ALOHA Program to Drive Real-World Evidence with Obagi® saypha® MagIQ™</title>
      <link>https://6ix.com/company/waldencast-acquisition-corp/news/update-obagi-medical-and-alpha-aesthetic-partners-announce-their-collaboration-in-the-aloha-program-to-drive-real-world-evidence-with-obagir-sayphar-magiqtm</link>
      <guid isPermaLink="true">https://6ix.com/company/waldencast-acquisition-corp/news/update-obagi-medical-and-alpha-aesthetic-partners-announce-their-collaboration-in-the-aloha-program-to-drive-real-world-evidence-with-obagir-sayphar-magiqtm</guid>
      <pubDate>Tue, 27 Jan 2026 05:00:00 GMT</pubDate>
      <description>Alpha selected as the first Medspa platform partner given their commitment to innovation, education, and breaking through barriers NEW YORK and SACRAMENTO,</description>
    </item>
    <item>
      <title>Obagi Medical and Alpha Aesthetic Partners Announce Their Collaboration in the ALOHA Program to Drive Real-World Evidence with Obagi® saypha® MagIQ™</title>
      <link>https://6ix.com/company/waldencast-acquisition-corp/news/obagi-medical-and-alpha-aesthetic-partners-announce-their-collaboration-in-the-aloha-program-to-drive-real-world-evidence-with-obagir-sayphar-magiqtm</link>
      <guid isPermaLink="true">https://6ix.com/company/waldencast-acquisition-corp/news/obagi-medical-and-alpha-aesthetic-partners-announce-their-collaboration-in-the-aloha-program-to-drive-real-world-evidence-with-obagir-sayphar-magiqtm</guid>
      <pubDate>Tue, 27 Jan 2026 05:00:00 GMT</pubDate>
      <description>Alpha selected as the first Medspa platform partner given their commitment to innovation, education, and breaking through barriers NEW YORK and SACRAMENTO,</description>
    </item>
    <item>
      <title>CORRECTION – Obagi Medical and Platinum Dermatology Partners Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™</title>
      <link>https://6ix.com/company/waldencast-acquisition-corp/news/correction-obagi-medical-and-platinum-dermatology-partners-announce-collaboration-in-the-aloha-program-to-drive-real-world-evidence-for-obagir-sayphar-magiqtm</link>
      <guid isPermaLink="true">https://6ix.com/company/waldencast-acquisition-corp/news/correction-obagi-medical-and-platinum-dermatology-partners-announce-collaboration-in-the-aloha-program-to-drive-real-world-evidence-for-obagir-sayphar-magiqtm</guid>
      <pubDate>Mon, 26 Jan 2026 05:00:00 GMT</pubDate>
      <description>Platinum selected as the first dermatology platform partner due to its commitment to clinical evidence and dissemination across its network of practices In a</description>
    </item>
    <item>
      <title>Obagi Medical and Platinum Dermatology Partners Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™</title>
      <link>https://6ix.com/company/waldencast-acquisition-corp/news/obagi-medical-and-platinum-dermatology-partners-announce-collaboration-in-the-aloha-program-to-drive-real-world-evidence-for-obagir-sayphar-magiqtm</link>
      <guid isPermaLink="true">https://6ix.com/company/waldencast-acquisition-corp/news/obagi-medical-and-platinum-dermatology-partners-announce-collaboration-in-the-aloha-program-to-drive-real-world-evidence-for-obagir-sayphar-magiqtm</guid>
      <pubDate>Mon, 26 Jan 2026 05:00:00 GMT</pubDate>
      <description>Platinum selected as the first dermatology platform partner due to its commitment to clinical evidence and dissemination across its network of practices NEW</description>
    </item>
    <item>
      <title>Obagi Medical Unveils ALOHA Program to Launch Obagi® saypha® MagIQ™ – Pioneering the Largest Real-World Evaluation of a New Hyaluronic Acid Filler</title>
      <link>https://6ix.com/company/waldencast-acquisition-corp/news/obagi-medical-unveils-aloha-program-to-launch-obagir-sayphar-magiqtm-pioneering-the-largest-real-world-evaluation-of-a-new-hyaluronic-acid-filler</link>
      <guid isPermaLink="true">https://6ix.com/company/waldencast-acquisition-corp/news/obagi-medical-unveils-aloha-program-to-launch-obagir-sayphar-magiqtm-pioneering-the-largest-real-world-evaluation-of-a-new-hyaluronic-acid-filler</guid>
      <pubDate>Wed, 21 Jan 2026 05:00:00 GMT</pubDate>
      <description>Program Designed to Drive Real World, Practice Focused Evidence with Injectables &amp; Skincare NEW YORK, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Obagi Medical, a</description>
    </item>
    <item>
      <title>Waldencast Announces Q2 2025 Results and Provides Q3 2025 Trading Update</title>
      <link>https://6ix.com/company/waldencast-acquisition-corp/news/waldencast-announces-q2-2025-results-114500655</link>
      <guid isPermaLink="true">https://6ix.com/company/waldencast-acquisition-corp/news/waldencast-announces-q2-2025-results-114500655</guid>
      <pubDate>Mon, 24 Nov 2025 11:45:00 GMT</pubDate>
      <description>Transformation efforts drive performance improvements at Obagi Medical with accelerating revenue Contrasted performance for Milk Makeup with Q2 2025 net revenue growth driven by U.S. channel expansion and sell-out acceleration but softer performance in Q3 2025 in international markets Company advances key strategic initiatives, including expansion into medical aesthetics through the Novaestiq acquisition and strengthened balance sheet following the sale of the Obagi Japan trademark and credit fa</description>
    </item>
    <item>
      <title>Obagi Medical Shares New Clinical Data on Obagi Hyaluronic Acid Injectables and Nu-Cil Scalp Serum at the 2025 American Society for Dermatologic Surgery Annual Meeting</title>
      <link>https://6ix.com/company/waldencast-acquisition-corp/news/obagi-medical-shares-new-clinical-data-on-obagi-hyaluronic-acid-injectables-and-nu-cil-scalp-serum-at-the-2025-american-society-for-dermatologic-surgery-annual-meeting</link>
      <guid isPermaLink="true">https://6ix.com/company/waldencast-acquisition-corp/news/obagi-medical-shares-new-clinical-data-on-obagi-hyaluronic-acid-injectables-and-nu-cil-scalp-serum-at-the-2025-american-society-for-dermatologic-surgery-annual-meeting</guid>
      <pubDate>Sun, 16 Nov 2025 05:00:00 GMT</pubDate>
      <description>Obagi® saypha® ChIQ™ data selected as a top 10 cosmetic oral abstract presentation NEW YORK, Nov. 16, 2025 (GLOBE NEWSWIRE) -- Obagi Medical, a leading</description>
    </item>
  </channel>
</rss>